Schedule 13D ownership disclosure

CERO THERAPEUTICS HLDGS INC

Security class unavailable · CUSIP: 71902K105

Event date: 2023-01-27

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
78.2000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-23-020558
Form type
SC 13D
Filer
CERO THERAPEUTICS HOLDINGS, INC.
CIK
CIK 1870404
Filed
Feb 01, 2023
Reporting period
Jan 27, 2023
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub